[6-K] Haleon plc Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Haleon plc filed a Form 6-K notifying investors that Tracy Clarke, a current Non-Executive Director of Haleon, will be appointed as a Non-Executive Director of Inchcape plc effective 31 December 2025. The disclosure was made to satisfy paragraph 6.4.9R(2) of the UK Listing Rules and is presented as a director declaration in the exhibit. The report is dated 02 October 2025 and signed by Amanda Mellor, Company Secretary. The filing reiterates Haleon’s consumer health focus and lists major product categories and brands for context.

Positive

• Regulatory compliance: Disclosure made under paragraph 6.4.9R(2) of the UK Listing Rules
• Transparency: Haleon publicly notifies shareholders of a director's external board appointment effective 31 December 2025

Negative

• None.

Insights

Corporate Governance Specialist

TL;DR Director appointment to an external board disclosed to meet UK Listing Rules; routine governance transparency.

The filing is a standard director declaration required under UK Listing Rules and informs shareholders that Tracy Clarke will join the board of Inchcape plc on 31 December 2025. This is a governance disclosure rather than an operational or financial development. It confirms compliance with listing rule reporting obligations and provides assurance that the company is transparently reporting potential outside directorships held by its directors. There is no financial data or indication of time commitment or conflicts disclosed in this document.

Securities Analyst

TL;DR Non-material announcement; no earnings, transaction, or risk changes disclosed.

The report communicates a personnel update limited to a board appointment at another listed company. Such disclosures are typically immaterial to a company’s financial performance unless they involve executive-level changes, conflicts of interest, or significant time commitments; none of those are stated here. Investors receive timely compliance information but no new operational or financial metrics to reassess valuation or risk.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2025

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	O2 October 2025 - “Director Declaration”

99.1

Haleon plc: Director Declaration

02 October 2025: In accordance with paragraph 6.4.9R(2) of the UK Listing Rules, Haleon plc (LSE/NYSE: HLN) announces that Tracy Clarke, Non-Executive Director, will be appointed to the Board of Inchcape plc (LSE: INCH) as a Non-Executive Director effective 31 December 2025.

Amanda Mellor

Company Secretary

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com. 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: October 02, 2025	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary

FAQ

What did Haleon (HLN) disclose in this Form 6-K?

Haleon disclosed that Non-Executive Director Tracy Clarke will be appointed as a Non-Executive Director of Inchcape plc effective 31 December 2025.

When is Tracy Clarke's appointment to Inchcape plc effective?

The appointment is effective on 31 December 2025.

Why did Haleon file this Form 6-K?

The filing was made to comply with paragraph 6.4.9R(2) of the UK Listing Rules as a director declaration.

Who signed the disclosure on behalf of Haleon?

The disclosure lists Amanda Mellor as Company Secretary.

Does the filing include financial results or transactions?

No. The filing contains a director declaration and company background but does not include financial results or transactions.